Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05158985
Other study ID # 6786
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 15, 2020
Est. completion date November 1, 2022

Study information

Verified date December 2021
Source October 6 University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lateral epicondylitis is a tendinopathy injury involving the extensor muscles of the forearm. These muscles originate on the lateral epicondylar region of the distal humerus. the insertion of the extensor carpi radialis brevis is involved in most cases. Transdermal administration of an anti-inflammatory drug to specific area is one of the methods that used to decrease inflammation and increase cell metabolism


Description:

Lateral epicondylitis is a soft-tissue lesion of the tendinous origin of the wrist extensor muscles at their origin on the lateral humeral epicondyle. The extensor carpi radialis brevis is the area of most pathologic changes. It begins as a microtear of the tendinous origin of the wrist extensor muscles and results in degeneration and reactive granulation tissue formation. Activities involving prolonged or repeated gripping, wrist extension, forearm supination, and pronation cause eventual failure of the affected portion of the tendon. The mechanical failure of the tendon results in an ensuring tendinitis and symptoms of lateral epicondylitis. It is aggravated with movements of the wrist, by palpation of the lateral side of elbow, or by contraction of extensor muscles of the wrist. There are different treatment methods for lateral epicondylitis. Initially, lateral epicondylitis has been treated with ice, rest, counterforce tennis brace and/or non-steroidal anti-inflammatory drugs. But when the condition is not responding to initial treatment physical therapy is initiated


Recruitment information / eligibility

Status Recruiting
Enrollment 76
Est. completion date November 1, 2022
Est. primary completion date November 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: 1. Both sexes will be involved 2. Duration of the disease is more than 12 weeks. 3. Patient's age ranges from 20 to 40 years Exclusion Criteria: 1. Diabetic patients. 2. Hypertension patients. 3. Pregnant women 4. Cardiovascular patients 5. Patients with malunion fractures 6. Patients with cervical Radiclopathy 7. Patients with olecranon bursitis

Study Design


Related Conditions & MeSH terms


Intervention

Other:
phonophoresis
treatment
exercises
treatment

Locations

Country Name City State
Egypt Emad MOHAMED Cairo

Sponsors (1)

Lead Sponsor Collaborator
October 6 University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual analogue scale for pain intensity measurement A VAS is usually a horizontal line, 100 mm in length, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain". The patient marks on the line the point that they feel represents their perception of their current state 4 weeks
Primary Hand grip dynamometer for hand grip measurement The dynamometer has a dual scale readout which displays isometric grip force from 0-90 kg (0-200 lb). The outer dial registers the result in kg and the inner dial registers the result in lb. It has a peak hold needle which automatically retains the highest reading until the device is reset. The handle easily adjusts to five grip positions from 35-87 mm (1½ - 3¼") in 13 mm (½") increments. Always use the wrist strap to prevent the dynamometer from falling on the floor if accidentally dropped 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Recruiting NCT06336876 - Perceived Coping, Meaning, and Joy at Work N/A
Completed NCT04349761 - Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects Phase 1
Recruiting NCT04905095 - CSAPG Early Warning Score N/A
Completed NCT04438356 - M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness N/A
Recruiting NCT06216912 - Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy
Recruiting NCT05675930 - A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant Phase 2
Terminated NCT04659122 - A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia Phase 1
Completed NCT04029662 - Reducing Pain Intensity During Spinal Needle Insertion: Valsalva Maneuver vs. Control Technique N/A